Current practice and perception of screening for medication adherence in inflammatory bowel disease

Arvind J. Trindade, Donald E. Morisky, Adam C. Ehrlich, Andrew Tinsley, Thomas A. Ullman

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Adherence to medication in inflammatory bowel disease (IBD) improves outcomes. Current practices of screening for adherence to IBD medications are unknown. The goal of this study was to determine current practice and perception of screening for medication adherence among US-based gastroenterologists. Methods: A survey was mailed electronically to gastroenterologists whose electronic-mail address was listed in the American College of Gastroenterology database. Physicians who cared for IBD patients were invited to answer. Results: About 6830 surveys were sent to gastroenterologists nationwide, and 395 physicians who cared for IBD patients completed the survey. The true response rate is unknown, as the number of physicians caring for IBD patients in the database is unknown. About 77% (n=303) of physicians who responded stated they screen for adherence to medication. Of the 77% of physicians who screened for adherence, only 19% (n=58) use accepted measures of screening for adherence (pill counts, prescription refill rates, or adherence surveys). The remaining 81% used patient interview to screen for adherence, a measure considered least accepted to determine adherence, as it overestimates adherence. The average number of IBD patients observed in 1 week had no statistical significance in predilection for screening (P=0.82). Private practice physicians (P=0.05), younger physicians (P=0.03), and physicians with fewer years of experience (P=0.02) all were more likely to screen. About 95% of responders thought determining a low adherer to medicine was important because an intervention can increase adherence. Conclusions: The majority of gastroenterologists surveyed recognize that adherence to medication is important and improves outcomes. The majority of physicians in this study are screening for nonadherence in IBD, but are not using accepted measures for adherence detection. If this study truly reflects the majority of physicians nationwide, changing the way physicians screen for adherence, may detect more low adherers to medication.

Original languageEnglish (US)
Pages (from-to)878-882
Number of pages5
JournalJournal of Clinical Gastroenterology
Volume45
Issue number10
DOIs
StatePublished - Nov 1 2011
Externally publishedYes

Fingerprint

Medication Adherence
Inflammatory Bowel Diseases
Physicians
Databases
Private Practice
Prescriptions
Medicine
Interviews

Keywords

  • adherence
  • compliance
  • IBD
  • medication
  • screening

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Current practice and perception of screening for medication adherence in inflammatory bowel disease. / Trindade, Arvind J.; Morisky, Donald E.; Ehrlich, Adam C.; Tinsley, Andrew; Ullman, Thomas A.

In: Journal of Clinical Gastroenterology, Vol. 45, No. 10, 01.11.2011, p. 878-882.

Research output: Contribution to journalArticle

Trindade, Arvind J. ; Morisky, Donald E. ; Ehrlich, Adam C. ; Tinsley, Andrew ; Ullman, Thomas A. / Current practice and perception of screening for medication adherence in inflammatory bowel disease. In: Journal of Clinical Gastroenterology. 2011 ; Vol. 45, No. 10. pp. 878-882.
@article{b391a24ed4e34aab9df39ac6f3e76507,
title = "Current practice and perception of screening for medication adherence in inflammatory bowel disease",
abstract = "Background: Adherence to medication in inflammatory bowel disease (IBD) improves outcomes. Current practices of screening for adherence to IBD medications are unknown. The goal of this study was to determine current practice and perception of screening for medication adherence among US-based gastroenterologists. Methods: A survey was mailed electronically to gastroenterologists whose electronic-mail address was listed in the American College of Gastroenterology database. Physicians who cared for IBD patients were invited to answer. Results: About 6830 surveys were sent to gastroenterologists nationwide, and 395 physicians who cared for IBD patients completed the survey. The true response rate is unknown, as the number of physicians caring for IBD patients in the database is unknown. About 77{\%} (n=303) of physicians who responded stated they screen for adherence to medication. Of the 77{\%} of physicians who screened for adherence, only 19{\%} (n=58) use accepted measures of screening for adherence (pill counts, prescription refill rates, or adherence surveys). The remaining 81{\%} used patient interview to screen for adherence, a measure considered least accepted to determine adherence, as it overestimates adherence. The average number of IBD patients observed in 1 week had no statistical significance in predilection for screening (P=0.82). Private practice physicians (P=0.05), younger physicians (P=0.03), and physicians with fewer years of experience (P=0.02) all were more likely to screen. About 95{\%} of responders thought determining a low adherer to medicine was important because an intervention can increase adherence. Conclusions: The majority of gastroenterologists surveyed recognize that adherence to medication is important and improves outcomes. The majority of physicians in this study are screening for nonadherence in IBD, but are not using accepted measures for adherence detection. If this study truly reflects the majority of physicians nationwide, changing the way physicians screen for adherence, may detect more low adherers to medication.",
keywords = "adherence, compliance, IBD, medication, screening",
author = "Trindade, {Arvind J.} and Morisky, {Donald E.} and Ehrlich, {Adam C.} and Andrew Tinsley and Ullman, {Thomas A.}",
year = "2011",
month = "11",
day = "1",
doi = "10.1097/MCG.0b013e3182192207",
language = "English (US)",
volume = "45",
pages = "878--882",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Current practice and perception of screening for medication adherence in inflammatory bowel disease

AU - Trindade, Arvind J.

AU - Morisky, Donald E.

AU - Ehrlich, Adam C.

AU - Tinsley, Andrew

AU - Ullman, Thomas A.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Background: Adherence to medication in inflammatory bowel disease (IBD) improves outcomes. Current practices of screening for adherence to IBD medications are unknown. The goal of this study was to determine current practice and perception of screening for medication adherence among US-based gastroenterologists. Methods: A survey was mailed electronically to gastroenterologists whose electronic-mail address was listed in the American College of Gastroenterology database. Physicians who cared for IBD patients were invited to answer. Results: About 6830 surveys were sent to gastroenterologists nationwide, and 395 physicians who cared for IBD patients completed the survey. The true response rate is unknown, as the number of physicians caring for IBD patients in the database is unknown. About 77% (n=303) of physicians who responded stated they screen for adherence to medication. Of the 77% of physicians who screened for adherence, only 19% (n=58) use accepted measures of screening for adherence (pill counts, prescription refill rates, or adherence surveys). The remaining 81% used patient interview to screen for adherence, a measure considered least accepted to determine adherence, as it overestimates adherence. The average number of IBD patients observed in 1 week had no statistical significance in predilection for screening (P=0.82). Private practice physicians (P=0.05), younger physicians (P=0.03), and physicians with fewer years of experience (P=0.02) all were more likely to screen. About 95% of responders thought determining a low adherer to medicine was important because an intervention can increase adherence. Conclusions: The majority of gastroenterologists surveyed recognize that adherence to medication is important and improves outcomes. The majority of physicians in this study are screening for nonadherence in IBD, but are not using accepted measures for adherence detection. If this study truly reflects the majority of physicians nationwide, changing the way physicians screen for adherence, may detect more low adherers to medication.

AB - Background: Adherence to medication in inflammatory bowel disease (IBD) improves outcomes. Current practices of screening for adherence to IBD medications are unknown. The goal of this study was to determine current practice and perception of screening for medication adherence among US-based gastroenterologists. Methods: A survey was mailed electronically to gastroenterologists whose electronic-mail address was listed in the American College of Gastroenterology database. Physicians who cared for IBD patients were invited to answer. Results: About 6830 surveys were sent to gastroenterologists nationwide, and 395 physicians who cared for IBD patients completed the survey. The true response rate is unknown, as the number of physicians caring for IBD patients in the database is unknown. About 77% (n=303) of physicians who responded stated they screen for adherence to medication. Of the 77% of physicians who screened for adherence, only 19% (n=58) use accepted measures of screening for adherence (pill counts, prescription refill rates, or adherence surveys). The remaining 81% used patient interview to screen for adherence, a measure considered least accepted to determine adherence, as it overestimates adherence. The average number of IBD patients observed in 1 week had no statistical significance in predilection for screening (P=0.82). Private practice physicians (P=0.05), younger physicians (P=0.03), and physicians with fewer years of experience (P=0.02) all were more likely to screen. About 95% of responders thought determining a low adherer to medicine was important because an intervention can increase adherence. Conclusions: The majority of gastroenterologists surveyed recognize that adherence to medication is important and improves outcomes. The majority of physicians in this study are screening for nonadherence in IBD, but are not using accepted measures for adherence detection. If this study truly reflects the majority of physicians nationwide, changing the way physicians screen for adherence, may detect more low adherers to medication.

KW - adherence

KW - compliance

KW - IBD

KW - medication

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=80054108975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054108975&partnerID=8YFLogxK

U2 - 10.1097/MCG.0b013e3182192207

DO - 10.1097/MCG.0b013e3182192207

M3 - Article

VL - 45

SP - 878

EP - 882

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 10

ER -